These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 14145442)

  • 21. THE PHENOMENON OF BACTERIOCINOGENY IN BACILLI OF THE GENUS KLEBSIELLA. I. CHARACTERISTICS OF KLEBSIELLA BACTERIOCINS.
    DURLAKOWA I; MARESZ BABCZYSZYN J; PRZONDO HESSEK A; LUSAR Z; MROZ KURPIELA E
    Arch Immunol Ther Exp (Warsz); 1964; 12():308-18. PubMed ID: 14186756
    [No Abstract]   [Full Text] [Related]  

  • 22. A MODIFICATION OF SANDYS' MEDIUM FOR INHIBITING THE SWARMING OF PROTEUS STRAINS.
    ANNEAR DI
    Aust J Exp Biol Med Sci; 1964 Dec; 42():723-4. PubMed ID: 14244710
    [No Abstract]   [Full Text] [Related]  

  • 23. Post-antibiotic effects of cefdinir on Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus pyrogenes.
    Howard BM; Pinney RJ; Smith JT
    Chemotherapy; 1994; 40(4):232-8. PubMed ID: 8082410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. THE NATURE OF INHIBITORY ACTIVITY BY STAPHYLOCOCCUS AUREUS TYPE 71.
    BARROW GI
    J Gen Microbiol; 1963 Aug; 32():255-61. PubMed ID: 14053272
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antibiotic-resistance in Italy: activity of the first year of the surveillance project AR-ISS].
    Boccia D; D'Ancona F; Salmaso S; Monaco M; Del Grosso M; D'Ambrosio F; Giannitelli S; Lana S; Fokas S; Pantosti A;
    Ann Ig; 2005; 17(2):95-110. PubMed ID: 16676730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. THE EFFECT OF COENZYME A INHIBITORS ON BACTERIAL GROWTH.
    BOSKOVIC B; POPOVIC Z; STERN P
    Acta Physiol Pharmacol Neerl; 1963; 12():513-9. PubMed ID: 14188017
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro bactericidal activity of cefepime and cefpirome against clinical isolates at Karachi.
    Arsalan A; Naqvi SB; Ali SA; Ahmed S; Shakeel O
    Pak J Pharm Sci; 2015 May; 28(3):841-7. PubMed ID: 26004702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the in vitro activity of tobramycin and gentamicin against 6,042 clinical isolates.
    Melby K; Midtvedt T; Dahl O
    Chemotherapy; 1979; 25(5):286-95. PubMed ID: 113179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). III Secular changes in susceptibility].
    Ogiwara M; Ishibashi K; Yoshida H; Imafuku Y; Murai M; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Watanabe K; Kobayashi Y; Uchida H; Ooe H; Nishikawa M; Matsuda S; Fujime M; Fujita K; Oka T; Takano Y; Miyagawa Y; Furuhama T; Kohno S; Hirakata Y; Mochida C
    Jpn J Antibiot; 1999 Mar; 52(3):177-267. PubMed ID: 10367263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of storage at 1 degree and 4 degrees C on viability and injury of Staphylococcus aureus, Escherichia coli and Streptococcus faecalis.
    Patterson TE; Jackson H
    J Appl Bacteriol; 1979 Feb; 46(1):161-7. PubMed ID: 35509
    [No Abstract]   [Full Text] [Related]  

  • 32. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.
    Lepak AJ; Andes DR
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4764-9. PubMed ID: 27216072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LABORATORY STUDIES ON GENTAMICIN.
    RUBENIS M; KOZIJ VM; JACKSON GG
    Antimicrob Agents Chemother (Bethesda); 1963; 161():153-6. PubMed ID: 14274883
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
    Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of volatile compounds produced by microbial growth in urine by selected ion flow tube mass spectrometry (SIFT-MS).
    Storer MK; Hibbard-Melles K; Davis B; Scotter J
    J Microbiol Methods; 2011 Oct; 87(1):111-3. PubMed ID: 21741416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A BACTERIOCINOGENIC TYPE 1 STRAIN OF KLEBSIELLA PNEUMONIAE.
    CLARKE CH; MACPHEE DG
    Experientia; 1965 Jan; 21():18. PubMed ID: 14283509
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). III. Differences in susceptibilities from previous years].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Kosakai N; Yamaguchi K; Matsumoto T; Kashitani F; Mochida C
    Jpn J Antibiot; 1997 Apr; 50(4):306-410. PubMed ID: 9192248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database--USA.
    Sahm DF; Marsilio MK; Piazza G
    Clin Infect Dis; 1999 Aug; 29(2):259-63. PubMed ID: 10476722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents: special references to bacteria isolated between July 1996 and June 1997].
    Mashita K; Shinagawa N; Ishikawa S; Hirata K; Denno R; Mukaiya M; Mizuno A; Ishibiki K; Ushijima Y; Kinoshita H; Morimoto K; Aikawa N; Yamazaki M; Fujimoto M; Iwai S; Kato K; Tanimura H; Ohnishi H; Maeda T; Sato T; Tanaka N; Inoue F; Iwagaki H; Yura J; Tanaka S
    Jpn J Antibiot; 1999 May; 52(5):398-430. PubMed ID: 10480049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996), III. Secular changes in susceptibility].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Mar; 51(3):143-236. PubMed ID: 9597551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.